ID   CIPm
AC   CVCL_L148
DR   Wikidata; Q54813366
RX   PubMed=19754820;
RX   PubMed=28283079;
RX   PubMed=33461558;
CC   Doubling time: 20.29 hours (PubMed=33461558).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Shih Tzu; VBO=VBO_0201223.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_L149 ! CIPp
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 16
//
RX   PubMed=19754820; DOI=10.1111/j.1476-5810.2006.00098.x;
RA   Uyama R., Nakagawa T., Hong S.-H., Mochizuki M., Nishimura R.,
RA   Sasaki N.;
RT   "Establishment of four pairs of canine mammary tumour cell lines
RT   derived from primary and metastatic origin and their E-cadherin
RT   expression.";
RL   Vet. Comp. Oncol. 4:104-113(2006).
//
RX   PubMed=28283079; DOI=10.1016/j.tvjl.2017.02.001;
RA   Yoshitake R., Saeki K., Watanabe M., Nakaoka N., Ong S.M.,
RA   Hanafusa M., Choisunirachon N., Fujita N., Nishimura R., Nakagawa T.;
RT   "Molecular investigation of the direct anti-tumour effects of
RT   nonsteroidal anti-inflammatory drugs in a panel of canine cancer cell
RT   lines.";
RL   Vet. J. 221:38-47(2017).
//
RX   PubMed=33461558; DOI=10.1186/s12917-020-02709-5; PMCID=PMC7814552;
RA   Levi M., Salaroli R., Parenti F., De Maria R., Zannoni A.,
RA   Bernardini C., Gola C., Brocco A., Marangio A., Benazzi C.,
RA   Muscatello L.V., Brunetti B., Forni M., Sarli G.;
RT   "Doxorubicin treatment modulates chemoresistance and affects the cell
RT   cycle in two canine mammary tumour cell lines.";
RL   BMC Vet. Res. 17:30.1-30.15(2021).
//